Atea Pharmaceuticals, Inc.
AVIR
$3.06
-$0.04-1.29%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -33.54M | -31.15M | -40.52M | -63.17M | -39.16M |
| Total Depreciation and Amortization | 104.00K | 104.00K | 104.00K | 104.00K | 104.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.58M | 9.57M | 9.70M | 9.10M | 7.81M |
| Change in Net Operating Assets | -8.54M | -1.56M | -11.48M | 14.10M | 9.41M |
| Cash from Operations | -30.40M | -23.04M | -42.20M | -39.87M | -21.83M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.37M | -122.01M | 124.69M | 56.80M | 27.77M |
| Cash from Investing | -3.37M | -122.01M | 124.69M | 56.80M | 27.77M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 0.00 | 117.00K | 0.00 | 150.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00 | 117.00K | 0.00 | 150.00K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -33.77M | -144.93M | 82.48M | 17.09M | 5.94M |
